Status:
RECRUITING
Walking ANalysis Interest in Persons wiTh facioscapulohumEral Muscular Dystrophies
Lead Sponsor:
Centre Hospitalier Universitaire Dijon
Conditions:
Facioscapulohumeral Dystrophy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Facioscapulohumeral muscular dystrophy (FSH) is one of the most common genetic myopathies in adults. It is characterised by progressive asymmetric muscular atrophy affecting the skeletal muscles of th...
Eligibility Criteria
Inclusion
- Patient :
- Adult ;
- Having given written consent;
- With an established molecular genetic diagnosis of FSH;
- Able to understand the instructions for carrying out the various tests;
- Able to walk for at least 6 minutes, even intermittently;
Exclusion
- Patient :
- Not affiliated to or not benefiting from a social security scheme;
- With one or more cardiorespiratory contraindications to a 6-minute test;
- With another neuro-orthopaedic history (other than FSH) that could significantly compromise walking ability;
- With cognitive problems preventing them from performing standardised tasks;
- Under legal protection (curatorship, guardianship).
- Who are subject to a legal protection measure;
- Pregnant, parturient or breast-feeding woman;
- Unable to benefit from longitudinal follow-up (D15 and M6).
Key Trial Info
Start Date :
April 3 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06600308
Start Date
April 3 2024
End Date
October 1 2026
Last Update
May 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Dijon Bourgogne
Dijon, France, 21000